» Articles » PMID: 1381507

Purification of a Murine Protein-tyrosine/threonine Kinase That Phosphorylates and Activates the Erk-1 Gene Product: Relationship to the Fission Yeast Byr1 Gene Product

Overview
Specialty Science
Date 1992 Sep 1
PMID 1381507
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

We report the purification to near homogeneity of a 45-kDa phorbol ester-stimulated protein kinase that phosphorylates and activates the Erk-1 gene product. This kinase, which we provisionally denote MEK for MAPK/Erk kinase, phosphorylated kinase-inactive Erk-1 protein primarily on a tyrosine residue and, to a lesser extent, on a threonine. We extend our previous results and show that two forms of purified MEK activated the myelin basic protein kinase encoded by Erk-1. MEK was inactivated by the serine/threonine phosphatase 2A but not by the protein-tyrosine phosphatase 1B. Sequence analysis of peptides generated by trypsin digestion of MEK revealed similarity to the proteins encoded by the Schizosaccharomyces pombe byr1 and Saccharomyces cerevisiae STE7 genes. These data are discussed with regard to a possible signal transduction mechanism.

Citing Articles

Autologous T-Cell-Free Antigen Presentation System Unveils hCMV-Specific NK Cell Response.

Ustiuzhanina M, Streltsova M, Timofeev N, Kryukov M, Chudakov D, Kovalenko E Cells. 2024; 13(6.

PMID: 38534374 PMC: 10969127. DOI: 10.3390/cells13060530.


Unveiling the domain-specific and RAS isoform-specific details of BRAF kinase regulation.

Trebino T, Markusic B, Nan H, Banerjee S, Wang Z Elife. 2023; 12.

PMID: 38150000 PMC: 10752582. DOI: 10.7554/eLife.88836.


TRIM11 Posttranscriptionally Modulated by miR-5193 Facilitates Tumor Growth and Metastasis of Prostate Cancer.

Pan Y, Yu H, Lu F Technol Cancer Res Treat. 2023; 22:15330338231178639.

PMID: 37248611 PMC: 10240878. DOI: 10.1177/15330338231178639.


Combined PARP inhibitors and small molecular inhibitors in solid tumor treatment (Review).

Jin N, Xia Y, Gao Q Int J Oncol. 2023; 62(2).

PMID: 36601757 PMC: 9851129. DOI: 10.3892/ijo.2023.5476.


Drug resistance in targeted cancer therapies with RAF inhibitors.

Degirmenci U, Yap J, Sim Y, Qin S, Hu J Cancer Drug Resist. 2022; 4(3):665-683.

PMID: 35582307 PMC: 9094075. DOI: 10.20517/cdr.2021.36.


References
1.
Posada J, Cooper J . Requirements for phosphorylation of MAP kinase during meiosis in Xenopus oocytes. Science. 1992; 255(5041):212-5. DOI: 10.1126/science.1313186. View

2.
Gomez N, Tonks N, Morrison C, Harmar T, Cohen P . Evidence for communication between nerve growth factor and protein tyrosine phosphorylation. FEBS Lett. 1990; 271(1-2):119-22. DOI: 10.1016/0014-5793(90)80386-w. View

3.
Wood K, Sarnecki C, Roberts T, Blenis J . ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell. 1992; 68(6):1041-50. DOI: 10.1016/0092-8674(92)90076-o. View

4.
Matsuda S, Kosako H, Takenaka K, Moriyama K, Sakai H, Akiyama T . Xenopus MAP kinase activator: identification and function as a key intermediate in the phosphorylation cascade. EMBO J. 1992; 11(3):973-82. PMC: 556538. DOI: 10.1002/j.1460-2075.1992.tb05136.x. View

5.
LAllemain G, Her J, Wu J, Sturgill T, Weber M . Growth factor-induced activation of a kinase activity which causes regulatory phosphorylation of p42/microtubule-associated protein kinase. Mol Cell Biol. 1992; 12(5):2222-9. PMC: 364394. DOI: 10.1128/mcb.12.5.2222-2229.1992. View